mRNA |
Imatinib |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
0.0002 |
mRNA |
Axitinib |
FIMM |
pan-cancer |
AAC |
0.44 |
0.003 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.005 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.009 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
0.083 |
0.009 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.009 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |